Articles
Page 21 of 27
-
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S35
-
Establishment and evaluation of transgenic models of Alzheimer's disease with senescence accelerated background
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S34 -
Protective effect of Curcumin on chronic cerebral ischemia by altering expression of α- synuclein in 2VO model
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S33 -
Some selenoproteins possibly involved in the development of Alzheimer’s disease: hints from the interaction proteins
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S32 -
Preventive effect of Curcumin on AD through increasing PS1/E-cadherin/beta-catenin complex mediated by E-cadherin
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S31 -
Testosterone regulates Arp2/3 expression by DNA methylation in hippocampus
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S27 -
Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L26 -
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S25 -
Selenite benefits embryonic stem cells therapy in the animal models of Parkinson’s disease through inhibiting inflammation
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L25 -
Prevention of cognitive deficits in Alzheimer’s mouse model by elevating brain magnesium
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L24 -
Reticulon 3 aggregation and its role in the formation of dystrophic neurites
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L23 -
Identifying an APP-binding protein in neuronal cell death
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L22 -
C-terminal part of alpha-synuclein mediates its activity in promoting proliferation of dopaminergic cells
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S21 -
The roles of fractalkine signaling in neurodegenerative disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L21 -
Epigenetic gambling & epigenetic drift as potential mechanisms underlying the quasi-stochastic distributions of late life neurodegenerative disorders
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L20 -
Self-renewal potential of NPCs decreased in vitro during human embryonic brain development with reduced activation of mitogen-activated protein kinases signaling
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S19 -
Mechanisms and models of TDP-43 proteinopathies
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L19 -
Novel circuitry and molecular pathogenic mechanisms in Huntington's disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L18 -
Retroviral vector-mediated hypoxia-regulated neurotrophin-3 gene transfer reduces apoptosis induced by hypoxia in PC12 cells
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S17 -
Neuropathology of transgenic HD animal models
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L17 -
The role of DJ-1 in anti-apoptosis
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L16 -
Gastrodin improves learning behavior in a rat model of Alzheimer's disease induced by intra-hippocampal Aβ 1-40 injection
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S15 -
Does axonopathy play a role in Parkinson's disease?
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L14 -
Beneficial effects of tri-lithium pyrroloquinoline quinonein on behaviors and pathology in a mouse model of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O14 -
A tet-on system for Drd1a-expressing cells
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O13 -
Effects of nicotine on gastric myoelectrical activity in ICR mice
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S13 -
Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L12 -
EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O12 -
DnaJB6: an indirect interaction protein of 15-kDa selenoprotein
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O11 -
Acetylcholinesterase blocks cleavage of APP by γ-secretase in 293 cells and mouse brain
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S11 -
Curcumin protects brain from oxidative stress through inducing expression of UCP2 in chronic cerebral hypoperfusion aging-rats
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S10 -
ApoE and apoE receptors in brain lipid metabolism and AD
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L10 -
Formononetin could increase soluble-APPα secretion by up-regulating ADAM10 level
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O10 -
β - but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L9 -
The study of the association of the p35 rs17852832 SNP polymorphism with Alzheimer’s disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S9 -
Deciphering the role of APP in synaptic function
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L7 -
Curcumin promotes cholesterol efflux from brain through LXR/RXR-ABCA1-apoA1 pathway in chronic cerebral hypoperfusion aging-rats
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S7 -
Chronic cerebral hypoperfusion induces UCP2 expression by decreasing mitochondrial respiratory activities in aging rat brain
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O6 -
Wnt signaling receptor LRP6 interacts with amyloid precursor protein and regulates its trafficking and processing
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O5 -
Structure-function relationship of γ-secretase
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L5 -
Effects of an early- and late-stage treatment with Geniposide on cognitive dysfunction in a transgenic mouse model relevant to Alzheimer's disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S4 -
Molecular mechanisms for simvastatin-mediated enhancement of synaptic plasticity
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O4 -
Dynamic neuronal regulatory network during the progression of Alzheimer’s disease suggests an adaptive survival strategy
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O3 -
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L3 -
Curcumin preserves cognitive function and improve serum HDL in chronic cerebral hypoperfusion aging-rats
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S3 -
Neuroprotective efficacy of ABCA1 and HDL in aging rats with cerebrovascular hypoperfusion
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S2 -
Lysosomal function in neurodegenerative diseases
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O2 -
Aggregation of TDP-43 fragments triggers cellular aberrant function: implication in neurodegeneration
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O1 -
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):L1 -
Chronic cerebral hypoperfusion induces ABCA1 and apolipoprotein A I mediated cellular cholesterol efflux by activating LXR/RXR in aging rat brain
Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S1
Follow
- ISSN: 1750-1326 (electronic)